Cargando…
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
Adoptive T cell therapy involves the ex vivo selection and expansion of effector cells for the treatment of patients with cancer. In this review, the advantages and limitations of using antigen-specific T cells are discussed in counterpoint to vaccine strategies. Although vaccination strategies repr...
Autor principal: | Yee, Cassian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131930/ https://www.ncbi.nlm.nih.gov/pubmed/15860133 http://dx.doi.org/10.1186/1479-5876-3-17 |
Ejemplares similares
-
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
por: Ghaffari, Sasan, et al.
Publicado: (2021) -
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Abakushina, Elena V., et al.
Publicado: (2021) -
Peptide immunotherapy for childhood allergy - addressing translational challenges
por: Mackenzie, Karen J, et al.
Publicado: (2011) -
Challenges and new technologies in adoptive cell therapy
por: Zhang, Pengchao, et al.
Publicado: (2023) -
Adoptive immunotherapy against ovarian cancer
por: Mittica, Gloria, et al.
Publicado: (2016)